These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20427188)
1. Oncomodulatory mechanisms of human cytomegalovirus in gliomas. Barami K J Clin Neurosci; 2010 Jul; 17(7):819-23. PubMed ID: 20427188 [TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus infection and expression in human malignant glioma. Cobbs CS; Harkins L; Samanta M; Gillespie GY; Bharara S; King PH; Nabors LB; Cobbs CG; Britt WJ Cancer Res; 2002 Jun; 62(12):3347-50. PubMed ID: 12067971 [TBL] [Abstract][Full Text] [Related]
3. Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. Cinatl J; Vogel JU; Kotchetkov R; Wilhelm Doerr H FEMS Microbiol Rev; 2004 Feb; 28(1):59-77. PubMed ID: 14975530 [TBL] [Abstract][Full Text] [Related]
4. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cobbs CS; Soroceanu L; Denham S; Zhang W; Kraus MH Cancer Res; 2008 Feb; 68(3):724-30. PubMed ID: 18245472 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus as an oncomodulatory agent in the progression of glioma. Joseph GP; McDermott R; Baryshnikova MA; Cobbs CS; Ulasov IV Cancer Lett; 2017 Jan; 384():79-85. PubMed ID: 27777041 [TBL] [Abstract][Full Text] [Related]
6. Consensus on the role of human cytomegalovirus in glioblastoma. Dziurzynski K; Chang SM; Heimberger AB; Kalejta RF; McGregor Dallas SR; Smit M; Soroceanu L; Cobbs CS; Neuro Oncol; 2012 Mar; 14(3):246-55. PubMed ID: 22319219 [TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus viral load in tumor and peripheral blood samples of patients with malignant gliomas. Priel E; Wohl A; Teperberg M; Nass D; Cohen ZR J Clin Neurosci; 2015 Feb; 22(2):326-30. PubMed ID: 25443081 [TBL] [Abstract][Full Text] [Related]
8. Human Cytomegalovirus DNA Quantification and Gene Expression in Gliomas of Different Grades. Stangherlin LM; Castro FL; Medeiros RS; Guerra JM; Kimura LM; Shirata NK; Nonogaki S; Dos Santos CJ; Carlan Silva MC PLoS One; 2016; 11(7):e0159604. PubMed ID: 27458810 [TBL] [Abstract][Full Text] [Related]
9. HCMV infection: modulating the cell cycle and cell death. Castillo JP; Kowalik TF Int Rev Immunol; 2004; 23(1-2):113-39. PubMed ID: 14690857 [TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus infection contributes to glioma disease progression via upregulating endocan expression. Xing Y; Wang Y; Wang S; Wang X; Fan D; Zhou D; An J Transl Res; 2016 Nov; 177():113-126. PubMed ID: 27474433 [TBL] [Abstract][Full Text] [Related]
11. Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients. Shamran HA; Kadhim HS; Hussain AR; Kareem A; Taub DD; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP Biomed Res Int; 2015; 2015():642652. PubMed ID: 25710012 [TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity. Varani S; Frascaroli G; Landini MP; Söderberg-Nauclér C Rev Med Virol; 2009 May; 19(3):131-45. PubMed ID: 19367559 [TBL] [Abstract][Full Text] [Related]
13. Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and In vivo. Sinzger C; Bissinger AL; Viebahn R; Oettle H; Radke C; Schmidt CA; Jahn G J Infect Dis; 1999 Oct; 180(4):976-86. PubMed ID: 10479121 [TBL] [Abstract][Full Text] [Related]
14. Building a mouse model hallmarking the congenital human cytomegalovirus infection in central nervous system. Tang JL; Wang ML; Qiu JJ; Wu D; Hu W; Shi BF; Hu Y; Li JP Arch Virol; 2002 Jun; 147(6):1189-95. PubMed ID: 12111428 [TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Zhang T; Guan M; Xu C; Chen Y; Lu Y Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663 [TBL] [Abstract][Full Text] [Related]
16. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus. Yue Y; Barry PA Adv Virus Res; 2008; 72():207-26. PubMed ID: 19081492 [TBL] [Abstract][Full Text] [Related]
17. HCMV microinfections in inflammatory diseases and cancer. Söderberg-Nauclér C J Clin Virol; 2008 Mar; 41(3):218-23. PubMed ID: 18164235 [TBL] [Abstract][Full Text] [Related]
18. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? Söderberg-Nauclér C J Intern Med; 2006 Mar; 259(3):219-46. PubMed ID: 16476101 [TBL] [Abstract][Full Text] [Related]
19. Activation of telomerase by human cytomegalovirus. Strååt K; Liu C; Rahbar A; Zhu Q; Liu L; Wolmer-Solberg N; Lou F; Liu Z; Shen J; Jia J; Kyo S; Björkholm M; Sjöberg J; Söderberg-Nauclér C; Xu D J Natl Cancer Inst; 2009 Apr; 101(7):488-97. PubMed ID: 19318640 [TBL] [Abstract][Full Text] [Related]
20. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]